SureTrader Advertisement Advertisement
Home > Boards > US OTC > Cannabis >

Pazoo, Inc. (PZOO)

Add PZOO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Patent Pending, GreenHouse_IG
Search This Board:
Last Post: 11/28/2015 3:14:55 AM - Followers: 230 - Board type: Free - Posts Today: 1


Video Dave Cunic Pazoo, Inc. (PZOO) company presentation on September 10, 2015.


Video, Steep Hill PZOO Partner Sep 16, 2015

Episode 10: David Lampach, the co-founder and CEO of Steep Hill Labs

Steep Hill is the country’s leading cannabis science and technology firm. Since opening their first commercial cannabis lab in 2008, Steep Hill has grown immensely. They now have labs in CA, WA, CO, and NV with plans for expansion into NM and OR very soon. Brandon and David will dive into why testing cannabis is so important for consumers, medical v recreational cannabis differences, and the many new products coming out of their R&D lab including the QuantaCann and the GenKit.

Pazoo's testing lab subsidiaries and partners are in position to become the leading
cannabis testing and certification operation in the United States:

Top 4 reasons Pazoo is worth investing in
1) Steep Hill methodology and first right of refusal
They have been studying the plant and perfecting their testing methodology for 8+ years.

2) Strategic positioning
Pazoo has lab locations in the three most profitable states for testing (Nevada, Oregon, and Colorado- in that order). Testing will begin in all three by the 4th quarter (we could still have CO in the 3rd)

3) CannabisKing Distribution
Management has been proactive and created another revenue stream for the company with products expected to have substantial footholds in the sector (MJ Payments, AccuVape, and several others)

4) Transparency and Diligence of Management
David Cunic (CEO) and the pzoo team have been straightforward and upfront about their progress. There have been setbacks and delays that were out of their control, but they have used that time positively. They moved into the sector late last year and already have partnered with the best in class (Steep hill), have 3 testing labs, other revenue, and future expansion plans.

Competitive Advantage: PZOO's 2 primary competitors are Digipath (Nevada) and Cannlabs (Colorado).

1) Testing Methodology- The closest competitors have only been testing for 2-3 years and this has been evident in a various instances including the independent Nevada tests scoring Steep hill at 241/250 and the closest competitor around 190. CannLabs also recently could not perform tests promised to their customers due to lack of expertise.

2) Scope
Each of those competitors only have 1 lab, in 1 state, and have made 0 announcements about expansion. Pzoo will have 3 this year and has announced plans to open 2 more labs in 2016.

3) Effectiveness and Efficiency
Digipath had their first PR saying they were testing MJ in early June and claimed to be supplying the first open dispensary in Vegas. The reality is that they are only testing a couple samples a week and running their lab at a loss, bleeding cash. For all of you who want to be able to say we have "testing revenue coming in" this is our current alternative. Until substantial grow operations have produced crops, there is no point to having the facility open and running at a loss.

Potential Concerns:
1) Financing
Until Pzoo has steady revenue and is running at a profit (projected by end of Q4, but likely beginning of Q1 in 2016), having access to operating capital without taking out toxic debt will be imperative. The PR discussing Luchesi bringing them into contact with private financing is encouraging. Hopefully we will find out whether they were successful soon.

2) Federal Regulation
Like any company in the MJ sector, Federal regulation could severely hamper or halt PZOOs progress. There are no presidential candidates that have a legitimate chance of winning who have spoken out against the MJ industry at this point.

Pazoo, Inc. (OTCPK: PZOO)


Pazoo, Inc., is a company focused on health, wellness and safety.  Our focus is to provide best in class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities.  Through our wholly owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry leading laboratory testing of cannabis.  Pazoo’s license agreement with Steep Hill Labs Inc. allows us to use their best in market testing protocols on a right of first refusal basis as we expand throughout the USA.  Pazoo is licensed to test cannabis in Nevada, Colorado, and Oregon, with a focus on expansion into other states.
Our newest subsidiary is 100% wholly owned  CannabisKing Distribution, We’re making it easier for growing facilities, infusion companies and dispensaries to reap healthier sales with equipment, supplies and consumer products from, CannabisKing Distribution. Count on CannabisKing as your one-stop nationwide source for the highest quality goods, sales assistance and customer support.

Website information

stocktrademan  PZOO DD Links



Cannabis Quality Assurance Leader Steep Hill Lands $2mm in Additional Funding From Several Investors

BERKELEY, Calif., Nov. 9, 2015

"Morgan and Emily Paxhia, Founding Partners of Poseidon Asset Management said, “We have been deeply involved in making strategic cannabis investments in preparation for such milestones as the Medical Marijuana Regulation and Safety Act of 2015 and believe the best returns on investment will be those companies that are best positioned in advance of such enactment – Steep Hill is one of those companies.”

Pazoo Begins Generating Consulting Based Revenue With The Signing Of Operational Advisory Agreement For Denver Colorado Testing Lab Nov 9, 2015

Pazoo Inc (OTCMKTS:PZOO) Forms New Subsidiary To Sale Non-Controlled Hemp Related Products 10/30/2015

Friedman LLP (“Friedman”) is the Company’s new independent registered public accounting firm Oct 13, 2015

Pazoo, Inc., As Promised, Pays Off LG Capital LLC Note, Receives Traditional Investment Oct. 1, 2015

Pazoo expects be able to pay off other Notes within the next few weeks.


Pazoo, Inc. Receives $200,000 Loan To Make Las Vegas Testing Lab Fully Operational In November Of This Year Sept. 24, 2015

Pazoo has received a $200,000 Loan to be paid back from the revenue and earnings of the Las Vegas Facility.  There can be no debt to equity conversion as this is a more conventional form of financing.

Pazoo Wholly-Owned Subsidiary, CannabisKing Distribution, Adds A Revolutionary One-Of-A-Kind Patented Water Conservation Product Sept. 9, 2015

Pazoo, Inc. To Present On Cannabis InvestorWebcast Sept. 3, 2015

Pazoo, Inc. Subsidiary CannabisKing Distribution Adds Over 10 New Accounts; Company Receives Steady Reorders and Additional Commitments for AccuVape  Sept 2, 2015

Pazoo Signs Deal With New Consulting Company, Luchesi & Brand LLC  Aug. 31, 2015

Luchesi & Brand has already delivered business for CannabisKing for the AccuVape product line, has potential accounts for MJ Payment lined up, as well as connected some growers with our current testing labs

Transcript PZOO  Q2 2015 Earnings Conference Call  August 26, 2015 12:00 PM ET
Excerpt from CC
David Cunic - CEO
This is a great question, I am happy a shareholder emailed this to us. We believe the valuation of the company is highly undervalued, when you compares us to our main competitors and what their stock prices are currently at. One needs to remember we just went to the Marijuana sector less than a year ago and there is a very high barrier cost to enter the Marijuana sector and even higher level cost when entering the lab sector within the Marijuana industry. Now if you were to look at this year alone, let’s review some of the major accomplishment Pazoo has achieved in last seven months and I’m going to go through those right now.

Pazoo Wholly-Owned Subsidiary Harris Lee Announces Agreement in Principal with Harris Lee Colorado, LLC to Operate New Lab in Colorado Cannabis Testing Market- May 20, 2015

MoneyTV with Donald Baillargeon - May 15, 2015

Pazoo Provides Business Development Update - May 14, 2015

Pazoo, Inc 10K - May 14, 2015

Pazoo's Partner, MA & Associates, LLC, Joins Inaugural Nevada Cannabis Association - April 21, 2015

Pazoo Partner, MA and Associates, LLC Hires Industry Sales Vet Michael A. Tulimero to Head Up MA's Newly Created Marketing and Sales Division - April 13, 2015
Click for Read

Pazoo's Harris Lee to Take Over Operations at Colorado Marijuana Testing Facility - April 1, 2015
Click for Read

Pazoo Provides Business Development and Expansion Plan Update - March 31, 2015
Click for Read

Pazoo CEO Interview Money TV with Donald Baillargeon - March 20, 2015
Click to Read

Pazoo Launches Pazoo Investor Facebook Page, Posts Updates on Company and Las Vegas Facility Buildout Done by Ryan Taylor
March 19, 2015 

Click to Read

Pazoo Medical Marijuana Partner, MA & Associates, LLC, Receives a Two Year Exclusive Contract From One Grower for Up to 875,000 Square Feet of Grow - December 15, 2014
Click to Read



Address: 15A Saddle Road, Cedar Knolls, NJ 07927
Telephone: 855-729-6687 Website:
Fax: 973-455-0972 Email:


CEO: David Cunic
Issue Type: Common Stock
Auditors: MaloneBailey, LLP


Share Structure

Market Value $889,236,686 a/o March 12, 2015
Shares Outstanding  728,390,950 a/o Auguest 19, 2015
Float 449,536,555 a/o April 22, 2015
Authorized Shares 980,000,000 a/o April 22, 2015

Company Information

Pazoo, Inc.
15A Saddle Road
Cedar Knolls, NJ 07927

Investor Relations

Taylor Capitol, Inc.
Stephen Taylor
Phone: 973-351-3868

Transfer Agent

VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516


MaloneBailey, LLP


Investor Information






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
PZOO News: Quarterly Report (10-q) 11/16/2015 02:54:47 PM
PZOO News: Amended Quarterly Report (10-q/a) 11/16/2015 02:27:30 PM
PZOO News: Current Report Filing (8-k) 10/14/2015 03:23:10 PM
PZOO News: Securities Registration Statement (s-1/a) 10/01/2015 05:10:12 PM
PZOO News: Securities Registration Statement (s-1/a) 09/22/2015 12:41:39 PM
#11100  Sticky Note Conference Call Notes: mSollly 08/27/15 01:26:50 PM
#12029   This company is a pure dilutive machine with BlackSnake1 11/28/15 03:14:54 AM
#12028   Slow as it goes down, that is the jump1 11/25/15 09:51:31 PM
#12027   It is already mature IMO as I remember WillKillz 11/25/15 02:57:34 PM
#12026   Destruction of value by convertible debt at a BlackSnake1 11/25/15 11:53:53 AM
#12025   Destruction of value by convertible debt at a BlackSnake1 11/25/15 11:53:53 AM
#12024   I was only commenting (kidding) about another post. tarballmonger 11/25/15 11:04:10 AM
#12023   .0001 in near future for this pos! BlackSnake1 11/25/15 10:59:19 AM
#12022   .0001 in near future for this pos! BlackSnake1 11/25/15 10:59:19 AM
#12021   So who said it wasn't a growth stock? tarballmonger 11/25/15 10:29:48 AM
#12020   This stock about to pass a billion shares, CF904 11/25/15 10:27:27 AM
#12019   PZOO screwed all with their BS! BlackSnake1 11/25/15 09:58:19 AM
#12018   YAWN! tiller 11/23/15 02:17:01 PM
#12017   Any uptick in revenue will send this stock Dave_Cash 11/23/15 12:42:27 PM
#12016   You have to have MASS product to make jump1 11/23/15 12:30:35 PM
#12015   OK Dave Cash here is what I know LVDavid 11/23/15 11:37:51 AM
#12014   Don' worry Alan the cult following will now CF904 11/23/15 09:55:24 AM
#12013   Wasting your time bashing Pazoo. Even the people CF904 11/23/15 09:52:21 AM
#12012   They were shouting it from the rooftop! Alan Brochstein 11/23/15 09:26:25 AM
#12011   But they're TRYING, right? Jiminy Cricket 11/23/15 09:10:28 AM
#12010   It's almost December. Instead of operating 3 Alan Brochstein 11/20/15 06:08:02 PM
#12008   LVDavid, any update from your vantage point in Vegas? Dave_Cash 11/20/15 10:18:26 AM
#12007   If you are someone that has a short FollowThrough 11/19/15 08:36:30 PM
#12005   Correction PZOO Steep Hill Labs licensing agreement Patent Pending 11/17/15 06:31:03 PM
#12004   No p.r.? I guess there is no Alan Brochstein 11/17/15 03:57:19 PM
#12003   Sold this for .02 Glad I did :-D Whoa Cbdpotential 11/17/15 11:04:33 AM
#12002 New side Style mad72 11/17/15 09:23:22 AM
#12001   PAZOO : Management's Discussion and Analysis of Financial mad72 11/17/15 03:05:19 AM
#12000   Here is a link to my prior discussion: Alan Brochstein 11/16/15 11:12:07 PM
#11998   I think the skull and crossbones has been Alan Brochstein 11/16/15 07:29:26 PM
#11997   Wow. $6000 in sales. Seriously? Alan Brochstein 11/16/15 04:37:08 PM
#11996   Seems to be positive, but I personally haven't Jiminy Cricket 11/16/15 03:51:52 PM
#11995   Thanks, I'm at work can't read it. Good kioto1914 11/16/15 03:45:02 PM
#11994   It's on ihub, just click it Jiminy Cricket 11/16/15 03:43:14 PM
#11993   link ? bradstewart1865 11/16/15 03:29:31 PM
#11992   10qa out! kioto1914 11/16/15 02:36:39 PM
#11991   10 out! kioto1914 11/16/15 02:32:57 PM
#11990   lol Jiminy Cricket 11/16/15 01:10:59 PM
#11989   PAZOO going to PAZIP. tiller 11/16/15 12:35:42 PM
#11988   MM's hiding bids on L2 this could be Greenisgold 11/16/15 11:37:06 AM
#11987   Is there an explanation from pazoo ? mad72 11/16/15 05:20:31 AM
#11986   This will reach half a penny by months steveski90 11/13/15 09:53:25 PM
#11985   Yeah, it's junk. Moving on ... fintman 11/13/15 08:12:14 PM
#11984   Vexing because you listened to monkey the scammer fintman 11/13/15 08:11:53 PM
#11983   Vexing because it's a sub penny with revenue robsdaman 11/13/15 03:55:31 PM
#11982   Because this is the same talk, everyone has CF904 11/13/15 11:45:25 AM
#11981   Why is there no interest here? In Greenisgold 11/13/15 11:06:55 AM
#11980   Pazoo Reports from Marijuana Business Conference- MoneyTV with mad72 11/13/15 09:50:32 AM
#11979   I agree Patent Pending 11/10/15 10:46:17 AM
#11978   Hopefully I get my second nibble here. jump1 11/10/15 10:22:37 AM
#11977   Nice ;-)thx for the article mad72 11/10/15 08:22:39 AM